Previous studies have shown that PRMT5 levels are elevated in a wide variety of cancer cells including glioblastoma, melanoma, non‐small cell lung carcinoma, lymphoma and leukaemia cells.11, 13, 18, 38. This evidence concerns the gene PRMT5 and lymphoma.